Taysha Gene Therapies, Inc.
TSHA • NASDAQ • Stock Fundamentals
Taysha Gene Therapies, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean Nolan, with a market cap of $1.6B.
Market Cap$1.6B
Employees52.0
CEOSean Nolan
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Taysha Gene Therapies, Inc. FAQ
Common questions about Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.6B and trades on NASDAQ.
Taysha Gene Therapies, Inc. has approximately 52 employees.